282 related articles for article (PubMed ID: 28204994)
1. Prevalence of aromatase inhibitor-induced arthralgia in breast cancer: a systematic review and meta-analysis.
Beckwée D; Leysen L; Meuwis K; Adriaenssens N
Support Care Cancer; 2017 May; 25(5):1673-1686. PubMed ID: 28204994
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic options for aromatase inhibitor-associated arthralgia in breast cancer survivors: A systematic review of systematic reviews, evidence mapping, and network meta-analysis.
Kim TH; Kang JW; Lee TH
Maturitas; 2018 Dec; 118():29-37. PubMed ID: 30415752
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the clinical effectiveness of treatments for aromatase inhibitor-induced arthralgia in breast cancer patients: a protocol for a systematic review and network meta-analysis.
Bae K; Song SY
BMJ Open; 2020 May; 10(5):e033461. PubMed ID: 32371507
[TBL] [Abstract][Full Text] [Related]
4. Acupuncture for Arthralgia Induced by Aromatase Inhibitors in Patients with Breast Cancer: A Systematic Review and Meta-analysis.
Liu X; Lu J; Wang G; Chen X; Xv H; Huang J; Xue M; Tang J
Integr Cancer Ther; 2021; 20():1534735420980811. PubMed ID: 33586504
[TBL] [Abstract][Full Text] [Related]
5. Acupuncture and Vitamin D for the Management of Aromatase Inhibitor-Induced Arthralgia.
Anand K; Niravath P
Curr Oncol Rep; 2019 Apr; 21(6):51. PubMed ID: 30997616
[TBL] [Abstract][Full Text] [Related]
6. Interventions for the Treatment of Aromatase Inhibitor-Associated Arthralgia in Breast Cancer Survivors: A Systematic Review and Meta-analysis.
Yang GS; Kim HJ; Griffith KA; Zhu S; Dorsey SG; Renn CL
Cancer Nurs; 2017; 40(4):E26-E41. PubMed ID: 27333128
[TBL] [Abstract][Full Text] [Related]
7. Effect of acupuncture on aromatase inhibitor-induced arthralgia in patients with breast cancer: A meta-analysis of randomized controlled trials.
Chen L; Lin CC; Huang TW; Kuan YC; Huang YH; Chen HC; Kao CY; Su CM; Tam KW
Breast; 2017 Jun; 33():132-138. PubMed ID: 28384564
[TBL] [Abstract][Full Text] [Related]
8. Genomic risk prediction of aromatase inhibitor-related arthralgia in patients with breast cancer using a novel machine-learning algorithm.
Reinbolt RE; Sonis S; Timmers CD; Fernández-Martínez JL; Cernea A; de Andrés-Galiana EJ; Hashemi S; Miller K; Pilarski R; Lustberg MB
Cancer Med; 2018 Jan; 7(1):240-253. PubMed ID: 29168353
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the clinical effectiveness of treatments for aromatase inhibitor-induced arthralgia in breast cancer patients: A systematic review with network meta-analysis.
Bae K; Lamoury G; Carroll S; Morgia M; Lim S; Baron-Hay S; Shin IS; Park SJ; Oh B
Crit Rev Oncol Hematol; 2023 Jan; 181():103898. PubMed ID: 36535489
[TBL] [Abstract][Full Text] [Related]
10. Aromatase inhibitor-induced arthralgia: a review.
Niravath P
Ann Oncol; 2013 Jun; 24(6):1443-9. PubMed ID: 23471104
[TBL] [Abstract][Full Text] [Related]
11. Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors.
Mao JJ; Stricker C; Bruner D; Xie S; Bowman MA; Farrar JT; Greene BT; DeMichele A
Cancer; 2009 Aug; 115(16):3631-9. PubMed ID: 19517460
[TBL] [Abstract][Full Text] [Related]
12. Current opinion of aromatase inhibitor-induced arthralgia in breast cancer in the UK.
Din OS; Dodwell D; Winter MC; Mori S; Coleman RE
Clin Oncol (R Coll Radiol); 2011 Dec; 23(10):674-80. PubMed ID: 21788122
[TBL] [Abstract][Full Text] [Related]
13. The time since last menstrual period is important as a clinical predictor for non-steroidal aromatase inhibitor-related arthralgia.
Kanematsu M; Morimoto M; Honda J; Nagao T; Nakagawa M; Takahashi M; Tangoku A; Sasa M
BMC Cancer; 2011 Oct; 11():436. PubMed ID: 21985669
[TBL] [Abstract][Full Text] [Related]
14. Current management of aromatase inhibitor-induced arthralgia.
Sahin S; Karatas F; Sever AR; Altundag K
J BUON; 2016; 21(1):17-20. PubMed ID: 27061525
[TBL] [Abstract][Full Text] [Related]
15. Effect of Tart Cherry on Aromatase Inhibitor-Induced Arthralgia (AIA) in Nonmetastatic Hormone-Positive Breast Cancer Patients: A Randomized Double-Blind Placebo-Controlled Trial.
Shenouda M; Copley R; Pacioles T; Lebowicz Y; Jamil M; Akpanudo S; Tirona MT
Clin Breast Cancer; 2022 Jan; 22(1):e30-e36. PubMed ID: 34275765
[TBL] [Abstract][Full Text] [Related]
16. Randomized controlled trial of high-dose versus standard-dose vitamin D3 for prevention of aromatase inhibitor-induced arthralgia.
Niravath P; Hilsenbeck SG; Wang T; Jiralerspong S; Nangia J; Pavlick A; Ademuyiwa F; Frith A; Ma C; Park H; Rigden C; Suresh R; Ellis M; Kent Osborne C; Rimawi MF
Breast Cancer Res Treat; 2019 Sep; 177(2):427-435. PubMed ID: 31218477
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D Levels, Vitamin D Receptor Polymorphisms, and Inflammatory Cytokines in Aromatase Inhibitor-Induced Arthralgias: An Analysis of CCTG MA.27.
Niravath P; Chen B; Chapman JW; Agarwal SK; Welschhans RL; Bongartz T; Kalari KR; Shepherd LE; Bartlett J; Pritchard K; Gelmon K; Hilsenbeck SG; Rimawi MF; Osborne CK; Goss PE; Ingle JN
Clin Breast Cancer; 2018 Feb; 18(1):78-87. PubMed ID: 29128193
[TBL] [Abstract][Full Text] [Related]
18. Randomized Controlled Trial of a Home-Based Walking Program to Reduce Moderate to Severe Aromatase Inhibitor-Associated Arthralgia in Breast Cancer Survivors.
Nyrop KA; Callahan LF; Cleveland RJ; Arbeeva LL; Hackney BS; Muss HB
Oncologist; 2017 Oct; 22(10):1238-1249. PubMed ID: 28698390
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of management strategies for aromatase inhibitor-induced arthralgia in breast cancer patients: a systematic review.
Nahm N; Mee S; Marx G
Asia Pac J Clin Oncol; 2018 Dec; 14(6):374-382. PubMed ID: 29380528
[TBL] [Abstract][Full Text] [Related]
20. Genetic determinants of aromatase inhibitor-related arthralgia: the B-ABLE cohort study.
Garcia-Giralt N; Rodríguez-Sanz M; Prieto-Alhambra D; Servitja S; Torres-Del Pliego E; Balcells S; Albanell J; Grinberg D; Diez-Perez A; Tusquets I; Nogués X
Breast Cancer Res Treat; 2013 Jul; 140(2):385-95. PubMed ID: 23868189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]